Efficacy of Nintedanib for the Treatment of Patients With Radiation Pneumonitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
Int. J. Radiat. Oncol. Biol. Phys 2023 Mar 06;[EPub Ahead of Print], A Rimner, ZR Moore, S Lobaugh, A Geyer, DY Gelblum, RE Abdulnour, AF Shepherd, N Shaverdian, AJ Wu, J Cuaron, JE Chaft, MG Zauderer, J Eng, GJ Riely, CM Rudin, NV Els, M Chawla, M McCune, H Li, DR Jones, DM Sopka, CB Simone, R Mak, GL Weinhouse, Z Liao, DR Gomez, Z Zhang, PK PaikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.